ABCB1 and hepatocellular carcinoma: Systemic chemotherapy is not routinely used because HCC, unlike some other solid cancers, is considered to be chemoresistant with overexpressed dihydropyridine dehydrogenase, the multidrug resistance gene MDR-1, and P-glycoprotein gene product (Kim et al., 2017).